HumanFirst
HumanFirst, a subsidiary of ICON plc, specializes in biopharmaceutical research with a focus on Digital Health Technologies (DHTs) and digital biomarkers, serving major pharmaceutical companies in the United States.
Company Overview
HumanFirst is a segment of ICON plc specializing in biopharmaceutical research with a focus on precision measures. It offers a robust platform for integrating Digital Health Technologies (DHTs) and digital biomarkers into research processes. Serving many top pharmaceutical companies in the United States, HumanFirst has been instrumental in saving clients up to $3 million and reducing research time by up to one year.
HumanFirst Services
HumanFirst provides a comprehensive suite of services geared towards the development and deployment of precision measures in biopharmaceutical research. Key offerings include the Atlas Network, Atlas Connect, Atlas Insights, and Atlas API. Atlas Connect is a collaborative platform for developing precision measures, while Atlas Insights facilitates quick decision-making through curated research answers. The Atlas API allows for the creation of custom research tools atop the Atlas platform. These services are backed by an ecosystem of validated digital health technologies, digital biomarkers, eCOAs, research partners, and educational tools.
Digital Health Technologies and Biomarkers
HumanFirst's platform supports over 3,000 technologies and covers more than 1,000 medical conditions. It hosts an extensive database of over 15,000 physiological and behavioral measures, classified into 850+ categories. This expansive data repository includes more than 15,000 pieces of evidence such as clinical trials and FDA decisions, providing researchers with a rich resource for their biopharmaceutical studies.
HumanFirst Institute
The HumanFirst Institute offers a range of educational tools and research opportunities aimed at advancing the field of digital health technologies and precision measures. Through this institute, HumanFirst provides courses and research initiatives that empower researchers, healthcare professionals, and industry stakeholders with the knowledge and skills needed to utilize digital biomarkers and other advanced research tools effectively.